Control of Babesia equi parasitemia

Parasitology Today

Volumn 12, Issue 5, 1996, Pages 195-198

  Knowles Jr , Don P ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPARVAQUONE; IMIDOCARB; PARVAQUONE;

BABESIA; BABESIOSIS; CONTROLLED STUDY; HORSE; IMMUNE RESPONSE; INFECTION CONTROL; NONHUMAN; SHORT SURVEY; ULTRASTRUCTURE;

EID: 0029878180     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-4758(96)10007-7     Document Type: Article

References (30)

1. Friedhoff, K.T. (1982) The piroplasms of Equidae - significance for international commerce. Berl. Muench. Tieraerztl. Wochenschr. 95, 368-374
2. Schein, E. (1988) in Babesiosis of Domestic Animals and Man (M. Ristic, ed.), pp 197-208, CRC Press
3. Laveran, A. (1901) Contribution á l'étude de Piroplasma equi. C. R. Soc. Biol. 53, 385-388
4. Schein, E. et al. (1981) Babesia equi (Laveran 1901). I. Development in horses and in lymphocyte culture. Tropenmed. Parasitol. 32, 223-227
5. Zapf, F. and Schein, E. (1994) New findings in the development of Babesia (Theileria) equi (Laveran, 1901) in the salivary glands of the vector ticks, Hyalomma species. Parasitol. Res. 80, 543-548
6. Kawazu, S. et al. (1992) Analysis of the genes encoding immuno-dominant piroplasm surface proteins of Theileria sergenti and Theileria buffeli by nucleotide sequencing and polymerase chain reaction. Mol. Biochem. Parasitol. 57, 55-64
7. Dickson, J. and Shiels, B.R. (1993) Antigenic diversity of a major merozoite surface molecule in Theileria annulata. Mol. Biochem. Parasitol. 57, 55-64
8. Katende, J.M. et al. (1990) Identification of a Theileria mutans-specific antigen for use in an antibody and antigen detection ELISA. Parasite Immunol. 12, 419-433
9. Kappmeyer, L.S. et al. (1993) A Babesia equi gene encodes a surface protein with homology to Theileria species. Mol. Biochem. Parasitol. 62, 121-124
10. Allsopp, M.T.E.P. et al. (1994) Phylogeny and evolution of the piroplasms. Parasitology 108, 147-152
11. Knowles, R.C. (1988) Equine babesiosis: epidemiology, control and chemotherapy. Equine Vet. Sci. 8, 61-64
12. Knowles, D.P. et al. (1994) Specific immune resonses are required to control parasitemia in Babesia equi infection. Infect. Immun. 62, 1909-1913
13. Kurler, K.L. et al. (1987) Imidocarb and parvaquone in the treatment of piroplasmosis (Babesia equi) in equids. Am. J. Vet. Res. 11, 1613-1616
14. Zaugg, J.L. and Lane, V.M. (1989) Evaluations of buparvaquone as a treatment for equine babesiosis (Babesia equi). Am. J. Vet. Res. 50, 782-785
15. Zaugg, J.L. and Lane, V.M. (1992) Efficacy of buparvaquone as a therapeutic and clearing agent of Babesia equi of European origin in horses. Am. J. Vet. Res. 53, 1396-1399
16. Simpson, C.F. and Neal F.C. (1980) Ultrastructure of Babesia equi in ponies treated with imidocarb. Am. J. Vet. Res. 41, 267-271
17. Banerjee, D.P. et al. (1977) Cell-mediated immune response in equine babesiosis. Trop. Anim. Health Prod. 9, 153-158
18. Zweygarth, E. (1983) Cell-mediated immune response to Babesia egui-transformed lymphoblastoid cells in vitro. Zbl. Bakt. Hyg., I. Abt. Orig. 254, 281-289
19. Morrison, W.I. et al. (1995) Contribution of T-cell responses to immunity and pathogenesis in infectious with Theileria parva. Parasitology Today 11, 14-18
20. Brown, W.C. and Rice-Ficht, A.C. (1994) Use of helper T cells to identify potential vaccine antigens of Babesia bovis. Parasitology Today 10, 145-149
21. Knowles, D.P. et al. (1991) A monoclonal antibody defines geographically conserved surface protein epitope of Babesia equi merozoites. Infect. Immun. 59, 2412-2417
22. Ali, S. et al. (1993) Protein characterization of Babesia equi piroplasms isolated from infected horse erythrocytes. Parasitol. Res. 79, 639-643
23. Bose, R. and Hentrich, B. (1994) Identification of antigens diagnostic for European isolates of Babesia equi by two-dimensional electrophoresis and western blotting. Parasitol. Res. 80, 182-185
24. McGuire, T.C. and Poppie, M.J. (1973) Hypogammaglobulinemia and thymic hypoplasia in horses: a primary combined immuno-deficiency disorder. Infect. Immun. 8, 272-277
25. Ferryman, L.E. et al. (1988) Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection. J. Virol. 62, 3073-3076
26. Ferryman, L.E. et al. (1978) Maintenance of foals with combined immunodeficiency: causes and control of secondary infections. Am. J. Vet. Res. 39, 1043-1047
27. Magnuson, N.S. et al. (1984) Continuous cultivation of equine lymphocytes: evidence for occasional T cell-like maturation events in horses with hereditary severe combined immuno-deficiency. J. Immunol. 133, 2518-2524
28. Lunn, D.P. et al. (1995) Abnormal patterns of equine leukocyte differentiation antigen expression in severe combined immuno-deficiency foals suggests the phenotype of normal equine natural killer cells. Immunology 84, 495-499
29. Holman, P.J. et al. (1994) Babesia equi erythrocytic stage continuously cultured in an enriched medium. J. Parasitol. 80, 232-236
30. Zweygarth, E. et al. (1995) Continuous in vitro cultivation of erythrocytic stages of Babesia equi. Parasitol. Res. 81, 355-358